DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Y Hashimoto, TJ Zumwalt, A Goel - Epigenomics, 2016 - cir.nii.ac.jp
抄録< jats: p> Aberrant DNA methylation is frequently detected in gastrointestinal tumors,
and can therefore potentially be used to screen, diagnose, prognosticate, and predict …
and can therefore potentially be used to screen, diagnose, prognosticate, and predict …
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
Y Hashimoto, TJ Zumwalt, A Goel - Epigenomics, 2016 - europepmc.org
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
[HTML][HTML] DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Y Hashimoto, TJ Zumwalt, A Goel - Epigenomics, 2016 - ncbi.nlm.nih.gov
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Y Hashimoto, TJ Zumwalt, A Goel - Epigenomics, 2016 - pubmed.ncbi.nlm.nih.gov
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Y Hashimoto, TJ Zumwalt, A Goel - Epigenomics, 2016 - search.proquest.com
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …